Jubilant Life Science inks pact with Gilead to make remdesivir
- Covid-19 gave fresh life to the drug as it had shown antiviral activity against the SARS and MERS coronaviruses
- Remdesivir is also part of the World Health Organization’s Solidarity Trial which is underway across the world including at over half a dozen sites in India